首页> 外文期刊>Antiviral Research >Synergistic effects by combination of ganciclovir and tricin on human cytomegalovirus replication in vitro
【24h】

Synergistic effects by combination of ganciclovir and tricin on human cytomegalovirus replication in vitro

机译:更昔洛韦和三嗪合用对人巨细胞病毒体外复制的协同作用

获取原文
获取原文并翻译 | 示例
           

摘要

It has been demonstrated as the first report that combination treatment with ganciclovir (GCV) and tricin (4',5,7-trihydroxy-3',5'-dimethoxyflavone), a derivative of Sasa albo-marginata, after human cytomegalovirus (HCMV) infection has synergistic effects on both infectious virus production and HCMV DNA synthesis in the human embryonic fibroblast cell line MRC-5. In this paper, we examined the anti-HCMV effects of GCV plus various concentrations of tricin, and tricin plus various concentrations of GCV in MRC5 cells. We found that expression of the HCMV UL54 gene was significantly inhibited by combination of GCV with tricin when compared with GCV mono-treatment. These results suggest that tricin is a novel compound for combination therapy with GCV against HCMV replication. In addition, reduced-dose combination therapy may provide a direction for treatment in patients with HCMV infection while reducing drug toxicity. (C) 2015 Elsevier B.V. All rights reserved.
机译:作为第一个报道,已证明更昔洛韦(Sasa al-marginata)的衍生物更昔洛韦(GCV)和甘油三酸(4',5,7-三羟基-3',5'-二甲氧基黄酮)联合治疗后,人类巨细胞病毒(HCMV)感染对人类胚胎成纤维细胞系MRC-5中的感染性病毒产生和HCMV DNA合成均具有协同作用。在本文中,我们研究了MRC5细胞中GCV加上各种浓度的Tricin以及Tricin加上各种浓度GCV的抗HCMV作用。我们发现,与GCV单次治疗相比,HCV与Tricin的结合显着抑制了HCMV UL54基因的表达。这些结果表明,tricin是与GCV联合治疗HCMV复制的新型化合物。此外,减量联合疗法可为HCMV感染患者提供治疗指导,同时降低药物毒性。 (C)2015 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号